Loading…
Crow Tribe Land Restoration Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
98pct
436d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2009 · second_quarter · Indian/Native American Affairs
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Crow Tribe Land Restoration Act (S.1080)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Indian/Native American Affairs
Crow Tribe Land Restoration Act (S.1080)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Indian/Native American Affairs
Crow Tribe Land Restoration Act (S.1080)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Indian/Native American Affairs
Crow Tribe Land Restoration Act (S.1080)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Advocate for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including but not limited to H.R. 1038, S. 623, H.R. 5629, H.R. 1956, S. 1505, S. 1695). Food and Drug Administration Amendents Act of 2007 (H.R. 3580) Citizens Petitions, including but not limited to S. 25 and S. 1080 Counterfeit Drugs/Import safety/Pedigree Electronic prescribing (including H.R. 6331, S. 2408, and H.R. 4296) Prescription drug importation/re-importation Average Manufacturers Price/AMP
Client expense: Not reported · Firm income: $40,000
Government targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
Advocate for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including but not limited to H.R. 1038, S. 623, H.R. 5629, H.R. 1956, S. 1505, S. 1695). Food and Drug Administration Amendents Act of 2007 (H.R. 3580) Citizens Petitions, including but not limited to S. 25 and S. 1080 Counterfeit Drugs/Import safety/Pedigree Electronic prescribing (including H.R. 6331, S. 2408, and H.R. 4296) Prescription drug importation/re-importation Average Manufacturers Price/AMP
Client expense: Not reported · Firm income: $40,000
Government targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Indian/Native American Affairs
Crow Tribe Land Restoration Act (S.1080)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Indian/Native American Affairs
Crow Tribe Land Restoration Act (S.1080)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Indian/Native American Affairs
Crow Tribe Land Restoration Act (S.1080)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Health Issues
Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900) Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation).
Client expense: $2,530,000 · Firm income: Not reported
2007 · mid_year · Health Issues
Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900). Support efforts to promote public/private partnerships for health technology assessment (no specific legislation). Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill).
Client expense: Not reported · Firm income: $90,000
2007 · mid_year · Health Issues
Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900). Support efforts to promote public/private partnerships for health technology assessment (no specific legislation). Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill).
Client expense: $2,300,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)